MORPHOSYS had a very strong sell and decline within the last months. Many reasons, two are more important: The cancer drug "Monjuvi" is in delay and apparently there have been troubles in the scientifical research. Secondly, Constellation Pharmaceuticals bought MOR for billions of dollars, a takeover that did not effect the price-action in a positive way. These are the background news, more or less!

Technical Analysis is simple. Super-overbought on Daily and weekly chart on the RSI with a bullish divergence on both, daily and weekly. We probably found a bottom here. On the smaller timeframe, 4h, we have a bullsih div with an eventual Adam&Eve reversal.
Red is my target with 70% sell, rest is stoploss above entry and see where MOR might goes!

No financial advice, just my point of view

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.